Baxter Announces FDA Approval of Myxredlin, the First and Only Ready-To-Use Insulin for IV Infusion Read more
Sandoz announces first patient enrolled in clinical study for proposed biosimilar denosumab in osteoporosis Read more
ACADIA Pharmaceuticals Announces Top-line Results from Phase 3 ENHANCE Trial of Pimavanserin Read more
Vertex Submits New Drug Application to the FDA for Triple Combination Regimen of VX-445 (Elexacaftor), Tezacaftor and Ivacaftor in Cystic Fibrosis Read more
FDA Approves OTEZLA (apremilast) for the Treatment of Oral Ulcers Associated with Behçet’s Disease Read more
Celltrion and Nan Fung Group to establish Vcell Healthcare Limited to Develop and Commercialize Biosimilars in China Read more
MilliporeSigma and Broad Institute Announce CRISPR License Framework to Encourage Innovation Read more